FDA Orange Book · active-ingredient family
Methdilazine hydrochloride
Methdilazine hydrochloride: 1 brand, 1 generic; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 1 ANDA application approved.
Brands (NDA)
1
Generics (ANDA)
1
Listed patents
0
Presentations
3
Brand (NDA) products
Originator applications
- WESTWOOD SQUIBBNDA 011950—2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 8MG TABLET ORAL Discontinued — 4MG/5ML SYRUP ORAL Discontinued —
Generic (ANDA) products (1)
Abbreviated applications
- METHDILAZINE HYDROCHLORIDEALPHARMA US PHARMSANDA 087122—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 4MG/5ML SYRUP ORAL Discontinued —
Listed patents
Orange Book patent file
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Methdilazine hydrochloride: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
